AdipoSeeds Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $11.6M

  • Investors
  • 11

AdipoSeeds General Information

Description

Developer of a platelet-making system designed to solve the shortage of platelets in the world, and to create a future where a platelet-related treatment will be cheaply and safely provided. The company's platelet offers a novel technology for making platelets from mesenchymal stem cells without a complex and costly gene transfer along with a new blood supply system, enabling clients of the biotechnology industry with fat-derived platelets for blood products and wound care medicine.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10th floor, Mita Kokusai Building
  • 1-4-28 Mita, Minato-ku
  • Tokyo, 108-0073
  • Japan
+81
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 10th floor, Mita Kokusai Building
  • 1-4-28 Mita, Minato-ku
  • Tokyo, 108-0073
  • Japan
+81

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AdipoSeeds Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 12-Dec-2022 $11.6M Completed Clinical Trials - General
3. Early Stage VC 16-Oct-2020 Completed Clinical Trials - General
2. Seed Round 01-Nov-2019 Completed Startup
1. Early Stage VC 20-Dec-2017 Completed Startup
To view AdipoSeeds’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AdipoSeeds Patents

AdipoSeeds Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-6714932-B2 Method for producing vertebrate adipose tissue-derived mesenchymal cell line Active 01-Dec-2015
US-11518982-B2 Method for manufacturing mesenchymal cell line derived from vertebrate animal adipose tissue Active 01-Dec-2015
US-20200190474-A1 Method for manufacturing mesenchymal cell line derived from vertebrate animal adipose tissue Active 01-Dec-2015
JP-WO2017094260-A1 Method for producing vertebrate adipose tissue-derived mesenchymal cell line Active 01-Dec-2015
EP-3385372-A4 Method for manufacturing mesenchymal cell line derived from vertebrate animal adipose tissue Active 01-Dec-2015 C12N5/0653
To view AdipoSeeds’s complete patent history, request access »

AdipoSeeds Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
DCI Partners Venture Capital Minority
Gemseki Corporate Venture Capital Minority
MSF Capital Partners Corporation Minority
Nissay Capital Venture Capital Minority
SMBC Venture Capital Corporate Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

AdipoSeeds FAQs

  • When was AdipoSeeds founded?

    AdipoSeeds was founded in 2016.

  • Where is AdipoSeeds headquartered?

    AdipoSeeds is headquartered in Tokyo, Japan.

  • What industry is AdipoSeeds in?

    AdipoSeeds’s primary industry is Discovery Tools (Healthcare).

  • Is AdipoSeeds a private or public company?

    AdipoSeeds is a Private company.

  • What is AdipoSeeds’s current revenue?

    The current revenue for AdipoSeeds is .

  • How much funding has AdipoSeeds raised over time?

    AdipoSeeds has raised $11.6M.

  • Who are AdipoSeeds’s investors?

    DCI Partners, Gemseki, MSF Capital Partners, Nissay Capital, and SMBC Venture Capital are 5 of 11 investors who have invested in AdipoSeeds.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »